Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Use of CD33CAR modified high affinity NK cells (t-haNK) to reduce myeloid-derived suppressor cells suppressor activity (or reduce negative impact on NK cell activity)

US Patent 11813292 · Granted Nov 14, 2023

Assignee

Inventors

View full patent text on Google Patents →